BioCentury
ARTICLE | Financial News

AnGes looks to raise at least $51.2M

May 10, 2013 1:12 AM UTC

Japanese gene therapy company AnGes MG Inc. (Tokyo:4563) said it hopes to raise at least Y5.1 billion ($51.2 million) through May 19, 2014, through the exercise of 20,000 stock acquisition rights by Merrill Lynch Japan Securities. Each right entitles Merrill to purchase a share at 90% of the previous day's closing price, with a minimum exercise price of Y253,600, AnGes' closing price on April 30, the day before the deal was announced. AnGes was off Y27,000 to Y290,000 on Thursday. ...